Alignment Healthcare, Inc.

On July 10, 2026, the Company filed an action against the Centers for Medicare & Medicaid Services (“CMS”) and the Secretary of the U.S. Department of Health and Human Services in the U.S. District Court for the District of Columbia (Case No. 1:26-cv-02441) challenging CMS’s calculation of the Company’s Medicare Advantage Star Ratings for payment year 2027. The complaint alleges, among other things, that CMS’s use of certain measures and specifications that were not adopted through required notice-and-comment rulemaking to calculate the Company’s Star Ratings was in violation of the Administrative Procedure Act. The Company filed a motion for summary judgment on August 3, 2026, which has been fully briefed, and the parties are awaiting a potential hearing date and decision.

On October 9, 2026, the Company filed a separate action against CMS and the Secretary of the U.S. Department of Health and Human Services in the U.S. District Court for the District of Columbia (Case No. 1:26-cv-3550) challenging CMS’s calculation of the Company’s Medicare Advantage Star Ratings for payment year 2028. The complaint asserts claims consistent with those asserted in the Company’s payment year 2027 action regarding CMS’s use of certain Star Ratings measures and specifications and the calculation of the Company’s Star Ratings. For additional information regarding the Clover Health litigation, see Part II, Item 1A, “Risk Factors.”

The Company cannot predict the outcome of these proceedings.

For additional information on our legal proceedings, see Note 12, Commitments and Contingencies – Legal Proceedings, to Alignment Healthcare, Inc.'s Condensed Consolidated Financial Statements in Part I, Item 1 of this Quarterly Report.